Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
Purity:
95.00%
CAS Number:
[2169232-81-7]
Target:
Others
T35390
* VAT and and shipping costs not included. Errors and price changes excepted